🇪🇺 Colestimide in European Union

Colestimide (colestilan) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/002377
  • Local brand name: BindRen
  • Status: withdrawn

Colestimide in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in European Union

Frequently asked questions

Is Colestimide approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Colestimide in European Union?

Tanabe Pharma Corporation is the originator. The local marketing authorisation holder may differ — check the official source linked above.